Amit Gupta - Apr 1, 2025 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Role
Chief Executive Officer, Director
Signature
/s/ Nick Lynton, Attorney-in-Fact
Stock symbol
CDLX
Transactions as of
Apr 1, 2025
Transactions value $
-$13,260
Form type
4
Date filed
4/3/2025, 04:12 PM
Previous filing
Feb 19, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDLX Common Stock Options Exercise +14.4K +3.94% 378K Apr 1, 2025 Direct F1
transaction CDLX Common Stock Sale -$13.3K -7.34K -1.94% $1.81 371K Apr 2, 2025 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDLX Restricted Stock Units Options Exercise $0 -14.4K -20% $0.00 57.4K Apr 1, 2025 Common Stock 14.4K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.
F2 Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on April 1, 2025. The Reporting Person did not sell shares for any other purpose.
F3 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $1.78 to $1.865, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).
F4 The RSU award was originally for 114,796 shares. The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date.